About us

Baby's Breath Ltd. is a medical device company established by leading experts and highly experienced professionals dedicated to the development, production and distribution of breakthrough inhalation technologies that meet existing medical and market needs.

Baby's Breath is fully owned by the newly established New Air Inc. (Maryland), bringing our solutions to the North American market.

The company's vision is to enhance patient's wellbeing by improving the effectiveness of treatment through more user compliant products.

More acceptable treatment technologies with better symptom control and easier treatment administration will lead to faster health improvement, and help reduce hospital and outpatient costs.

Baby's Breath's flagship product, BabyAir is a unique solution to the problem of non-compliance of babies to receive aerosol-based medications through traditional face masks.

Demonstrating the company's ability to develop innovative approaches to long unsolved problems, BabyAir employs an ingenious 'hood' technique that creates a safe, easy & highly effective way to directly deliver inhaled medications to infants without physical contact, whether they are awake or asleep.

Extensive clinical trials suggest that BabyAir is far more effective than traditional masks, allowing infants to recover faster because they actually receive and absorb the optimum dose of medication.

BabyAir is the first of a number of breakthrough inhalation devices that Baby's Breath Ltd. intends to introduce to the market especially designed for the millions of patients with respiratory problems.